Stapes footplate defect as a source of CSF leak and otogenic meningitis in a patient with a cochlear implant

Vartanyan, Maria; Hill, Fiona; Orimoto, Kumiko; O’Leary, Stephen

doi:10.1177/0145561319864177

Cited by 1 publication

(2 citation statements)

References 1 publication

Supporting

Mentioning

Contrasting

Order By: Relevance

“…27 Certain factors increase the risk of meningitis. Stapes footplate defects 31 and CSF leaks 35 are risk factors in the development of meningitis in cochlear implant recipients. Our study results suggest that CSF leaks present with meningitis with greater frequency than meningitis without CSF leaks.…”

Section: Discussionmentioning

confidence: 99%

“…28 Other retrospective chart reviews have cited inner-ear malformations as a risk factor for CSF leaks in paediatric and adult populations. 29,30 Other anatomical variations, such as stapes footplate defects 31 and air–bone gaps 32 predisposed cochlear implant recipients to CSF leaks. Obesity 33 and X-linked deafness 34 have also been cited as risk factors for CSF leaks.…”

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

Complications of cochlear implants: a MAUDE database study

2023

View full text Add to dashboard Cite

Objective. A retrospective cross-sectional analysis was conducted of the US Food and Drug Administration's MAUDE (Manufacturer and User Facility Device Experience) database, to evaluate the complication profile of cochlear implantation according to manufacturer. Methods. A review of the MAUDE database was conducted from 1 January 2010 to 31 December 2020. Complications, including infection, extrusion, facial nerve stimulation, meningitis and cerebrospinal fluid leak, were identified using key word searches. The categorised data were analysed using a chi-square test to determine a difference in global complication incidence between three major cochlear implant manufacturers: manufacturer A (Cochlear Limited), manufacturer B (Med-El) and manufacturer C (Advanced Bionics). Results. A total of 31 857 adverse events were analysed. Implants of manufacturer C were associated with a statistically higher rate of infection (0.97 per cent), cerebrospinal fluid leak (0.07 per cent), extrusion (0.44 per cent) and facial nerve stimulation (0.11 per cent). Implants of manufacturer B were associated with a statistically higher rate of meningitis (0.07 per cent). Conclusion. Consideration of patient risk factors along with cochlear implant manufacturers can heighten awareness of cochlear implant complications pre-operatively, intra-operatively and post-operatively.

show abstract

Section: Discussionmentioning

confidence: 99%